Gleevec™ for the Treatment of Chronic Myelogenous Leukemia: U.S. Food and Drug Administration Regulatory Mechanisms, Accelerated Approval, and Orphan Drug Status
- 1 October 2002
- journal article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 7 (5), 390-392
- https://doi.org/10.1634/theoncologist.7-5-390